Company intelligence / Profile preview

Mabqi

Grabels/Montpellier*, Occitanie, Francemabqi.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Mabqi has developed a robust pipeline of innovative therapeutic antibodies targeting high unmet needs in oncology. Their platform enables rapid discovery and optimization of fully human functional drug candidates. Lead assets include unique pH-sensitive features and are convertible to next-generation formats such as ADCs, TCEs, or CAR-T therapies. Recent €5 million funding supports advancement of their lead program MQI‑201[5]. Some assets are available for partnership/licensing.

Therapeutic areas
Oncology
Modalities
Fully human monoclonal antibodies (mAbs)Multispecific antibodiesConditionally active pH-dependent antibodiesAntibody-drug conjugates (ADCs)T-cell engagers (TCEs)CAR-T therapies (convertible leads)
Industry
Biotech
02

Drug pipeline

7 assets

MQI-181

Preclinical

6 more assets in the full pipeline.

Request access →
03

Partnerships

Partnerships with biopharmaceutical industry for discovery/development using proprietary libraries and know-how.Assets available for licensing/collaboration.[2]

Beyond the preview

Go deeper on Mabqi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mabqi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call